Ribometrix raises $30 million to target RNA with small molecules
Sunday, November 18, 2018 - 07:20
in Biology & Nature
The start-up hopes that blocking the RNA encoding undruggable proteins will lead to new treatments for cancer, neurodegenerative diseases, and more